Cellular Therapy and Transplantation最新文献

筛选
英文 中文
Results of allogeneic hemopoietic stem cell transplantation in patients with acute leukemia for different age groups 同种异体造血干细胞移植在不同年龄组急性白血病患者中的效果
Cellular Therapy and Transplantation Pub Date : 2022-12-29 DOI: 10.18620/ctt-1866-8836-2022-11-3-4-36-44
E. Semenova, O. Paina, P. Kozhokar, O. Slesarchuk, A. Borovkova, A. Frolova, Z. Rakhmanova, A. Osipova, L. Tsvetkova, S. Razumova, T. Bykova, S. Bondarenko, M. Latypova, T. Gindina, Elena Babenko, A. Alyanskiy, I. Barkhatov, B. Smirnov, L. Zubarovskaya
{"title":"Results of allogeneic hemopoietic stem cell transplantation in patients with acute leukemia for different age groups","authors":"E. Semenova, O. Paina, P. Kozhokar, O. Slesarchuk, A. Borovkova, A. Frolova, Z. Rakhmanova, A. Osipova, L. Tsvetkova, S. Razumova, T. Bykova, S. Bondarenko, M. Latypova, T. Gindina, Elena Babenko, A. Alyanskiy, I. Barkhatov, B. Smirnov, L. Zubarovskaya","doi":"10.18620/ctt-1866-8836-2022-11-3-4-36-44","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-36-44","url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"61 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88488925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to Reconsider Haematopoietic Cell Transplants in Chronic Myeloid Leukaemia? 是时候重新考虑造血细胞移植治疗慢性髓性白血病了?
Cellular Therapy and Transplantation Pub Date : 2022-12-29 DOI: 10.18620/ctt-1866-8836-2022-11-3-4-6-9
R. Peter Gale
{"title":"Time to Reconsider Haematopoietic Cell Transplants in Chronic Myeloid Leukaemia?","authors":"R. Peter Gale","doi":"10.18620/ctt-1866-8836-2022-11-3-4-6-9","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-6-9","url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83743574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review on CRISPR/Cas9 as a Novel Technique for Cancer Therapy CRISPR/Cas9作为肿瘤治疗新技术的研究进展
Cellular Therapy and Transplantation Pub Date : 2022-12-29 DOI: 10.18620/ctt-1866-8836-2022-11-3-4-10-24
Ali A. Saleem, Khalida K. Al-Kelaby
{"title":"A Review on CRISPR/Cas9 as a Novel Technique for Cancer Therapy","authors":"Ali A. Saleem, Khalida K. Al-Kelaby","doi":"10.18620/ctt-1866-8836-2022-11-3-4-10-24","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-10-24","url":null,"abstract":"as the problems that can be encountered during clinical investigations. In this regard, we intend to contribute to optimizing work on CRISPR/Cas9 as well as to focus on the probable future paths of this technology.","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"77 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78013013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis: side effects and the tools of their reduction 自体造血干细胞移植治疗多发性硬化症的大剂量免疫抑制疗法:副作用及其减少工具
Cellular Therapy and Transplantation Pub Date : 2022-12-29 DOI: 10.18620/ctt-1866-8836-2022-11-3-4-25-35
A. Polushin, A. Tsynchenko, Y. Zalyalov, Evgenia Lopatina, N. Totolyan, A. Kulagin
{"title":"High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis: side effects and the tools of their reduction","authors":"A. Polushin, A. Tsynchenko, Y. Zalyalov, Evgenia Lopatina, N. Totolyan, A. Kulagin","doi":"10.18620/ctt-1866-8836-2022-11-3-4-25-35","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-25-35","url":null,"abstract":"Summary High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation (HDIT-AHSCT) is a promising and effective method of treat-ment of autoimmune diseases, including multiple sclerosis. Over the past 20 years, the frequency and severity of side effects of therapy have been significantly reduced due to the accumulation of experience of transplant centers, changing principles of patient selection and decreased intensity of conditioning regimens. However, the medium-intensity therapeutic protocols may also be accompanied by complications. We have analyzed the literature data and our own experience on early and late side effects of HDIT-AHSCT. The profile of an appropriate schedule of HDIT-AHSCT is also presented, as determined by characteristics of the patients and the clinical course of multiple sclerosis. The types of HDIT-AHSCT are formulated, as based on the goals and expectations of the treatment approach.","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75504812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of therapy with blinatumomab and autologous CD3 cell transfusions in relapsing acute lymphoblastic leukemia: A single center experience 布利纳单抗和自体CD3细胞输注治疗复发性急性淋巴细胞白血病的疗效:单中心经验
Cellular Therapy and Transplantation Pub Date : 2022-12-29 DOI: 10.18620/ctt-1866-8836-2022-11-3-4-70-76
N. Stepanyan, T. Valiev, Ramil Fatkhullin, T. Pavlova, N. Tsaplina, K. Kirgizov, S. Varfolomeeva
{"title":"Efficacy of therapy with blinatumomab and autologous CD3 cell transfusions in relapsing acute lymphoblastic leukemia: A single center experience","authors":"N. Stepanyan, T. Valiev, Ramil Fatkhullin, T. Pavlova, N. Tsaplina, K. Kirgizov, S. Varfolomeeva","doi":"10.18620/ctt-1866-8836-2022-11-3-4-70-76","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-70-76","url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"95 6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87683824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tribute to Prof. Andrey Zaritskey from an international perspective 从国际视角向安德烈·扎里茨基教授致敬
Cellular Therapy and Transplantation Pub Date : 2022-12-29 DOI: 10.18620/ctt-1866-8836-2022-11-3-4-99-103
R. Hehlmann
{"title":"Tribute to Prof. Andrey Zaritskey from an international perspective","authors":"R. Hehlmann","doi":"10.18620/ctt-1866-8836-2022-11-3-4-99-103","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-99-103","url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75042188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tyrosine kinase inhibitors: relapse prophylaxis after allogeneic hematopoietic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia 酪氨酸激酶抑制剂:预防费城染色体阳性急性淋巴细胞白血病成人异体造血干细胞移植后复发
Cellular Therapy and Transplantation Pub Date : 2022-12-29 DOI: 10.18620/ctt-1866-8836-2022-11-3-4-45-59
K. Afanaseva, O. Pirogova, E. Bakin, A. Smirnova, E. Morozova, Y. Vlasova, I. Barkhatov, Tatiana Gindina, I. Moiseev, S. Bondarenko
{"title":"Tyrosine kinase inhibitors: relapse prophylaxis after allogeneic hematopoietic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia","authors":"K. Afanaseva, O. Pirogova, E. Bakin, A. Smirnova, E. Morozova, Y. Vlasova, I. Barkhatov, Tatiana Gindina, I. Moiseev, S. Bondarenko","doi":"10.18620/ctt-1866-8836-2022-11-3-4-45-59","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-45-59","url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"362 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77430631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Transition from the smoldering systemic mastocytosis to chronic mast cell leukemia: a clinical case 从闷烧性全身肥大细胞增多症到慢性肥大细胞白血病的转变:一例临床病例
Cellular Therapy and Transplantation Pub Date : 2022-12-29 DOI: 10.18620/ctt-1866-8836-2022-11-3-4-83-86
Zarema Abdulkhalikova, I. Barkhatov, V. Baykov, M. Barabanshikova, E. Morozova
{"title":"Transition from the smoldering systemic mastocytosis to chronic mast cell leukemia: a clinical case","authors":"Zarema Abdulkhalikova, I. Barkhatov, V. Baykov, M. Barabanshikova, E. Morozova","doi":"10.18620/ctt-1866-8836-2022-11-3-4-83-86","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-83-86","url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"314 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77458855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Post-liver transplant HCC recurrence: patterns, treatment, and outcome 肝移植后HCC复发:模式、治疗和结果
Cellular Therapy and Transplantation Pub Date : 2022-08-12 DOI: 10.18620/ctt-1866-8836-2022-11-2-39-44
M. Abdelfattah, H. Elsiesy
{"title":"Post-liver transplant HCC recurrence: patterns, treatment, and outcome","authors":"M. Abdelfattah, H. Elsiesy","doi":"10.18620/ctt-1866-8836-2022-11-2-39-44","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-2-39-44","url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74743127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scale-out cultivation of human dermal fibroblasts using robotic cell culture system: comparison of manual and automated processing 利用机器人细胞培养系统大规模培养人真皮成纤维细胞:人工和自动处理的比较
Cellular Therapy and Transplantation Pub Date : 2022-08-12 DOI: 10.18620/ctt-1866-8836-2022-11-2-63-71
F. Fadeyev, Dayana Sedneva-Lugovets, Oksana Madyarova
{"title":"Scale-out cultivation of human dermal fibroblasts using robotic cell culture system: comparison of manual and automated processing","authors":"F. Fadeyev, Dayana Sedneva-Lugovets, Oksana Madyarova","doi":"10.18620/ctt-1866-8836-2022-11-2-63-71","DOIUrl":"https://doi.org/10.18620/ctt-1866-8836-2022-11-2-63-71","url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91334508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信